US Patent 10214586 PD-L1 antibodies
Patent 10214586 was granted and assigned to Eli Lilly and Company on February, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10214586 PD-L1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
